Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel small molecule drugs to treat critically ill patients with serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their caregivers.
|
Medivation's business is built on the identification and rapid development of product candidates that have the potential to improve the standard of care in human diseases.
|
||||||||||||||||||||||||||||||||||||
 |
 |
| Medivation © 2012 |